Abiraterone acetate: Phase I data

In an open-label, multiple-dose, dose-escalation, U.K. Phase I trial

Read the full 99 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE